GR1003713B - Deoxy-sugars as cancer inhibiting agents - Google Patents

Deoxy-sugars as cancer inhibiting agents

Info

Publication number
GR1003713B
GR1003713B GR980100107A GR980100107A GR1003713B GR 1003713 B GR1003713 B GR 1003713B GR 980100107 A GR980100107 A GR 980100107A GR 980100107 A GR980100107 A GR 980100107A GR 1003713 B GR1003713 B GR 1003713B
Authority
GR
Greece
Prior art keywords
deoxy
sugars
cancer inhibiting
inhibiting agents
desoxysugars
Prior art date
Application number
GR980100107A
Other languages
Greek (el)
Other versions
GR980100107A (en
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR980100107A publication Critical patent/GR980100107A/en
Publication of GR1003713B publication Critical patent/GR1003713B/en

Links

Abstract

Desoxysugars such as 2-deoxy-D glucose or 2-deoxy-D glucosulose or 2-deoxy-D lactose or 2-deoxy-d ribose are found to be the active substances of cancer inhibiting concoctions, acting as interceptive agents and in particular as antigens via the immunity system against malignant neoplasms.These pharmaceutical compounds, the desoxysugars, can be used as aptines and thus as antigen determinative agents against other pathogenic factors of a pestiferous disease.
GR980100107A 1998-03-20 1998-03-20 Deoxy-sugars as cancer inhibiting agents GR1003713B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR98100107 1998-03-20

Publications (2)

Publication Number Publication Date
GR980100107A GR980100107A (en) 1999-11-30
GR1003713B true GR1003713B (en) 2001-11-07

Family

ID=10943348

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980100107A GR1003713B (en) 1998-03-20 1998-03-20 Deoxy-sugars as cancer inhibiting agents

Country Status (1)

Country Link
GR (1) GR1003713B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160865B2 (en) 2000-05-01 2007-01-09 Lampidis Theodore J Cancer treatment including glycolytic inhibitors

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062604A2 (en) 2003-01-10 2004-07-29 Threshold Pharmaceuticals, Inc. Treatment of cancer with 2-deoxyglucose

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160865B2 (en) 2000-05-01 2007-01-09 Lampidis Theodore J Cancer treatment including glycolytic inhibitors

Also Published As

Publication number Publication date
GR980100107A (en) 1999-11-30

Similar Documents

Publication Publication Date Title
DE69808130T2 (en) Adamantane derivatives
EP1374908A3 (en) Polymer-drug conjugates comprising hydrazide linkers
HK1045992A1 (en) Hydroxymatairesinol in cancer prevention.
NO20002785L (en) Adam Anta Derivatives
DK1143967T3 (en) Anticonvulsant derivatives suitable for the treatment of Horton's headache
MY125978A (en) Admantane derivatives
FI956014A (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
FI953442A0 (en) Freeze-dried beads containing gonadotropin
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
EP1423107A4 (en) Fatty alcohol drug conjugates
NO990595D0 (en) Use of the clikinol chelating agent in the preparation of a pharmaceutical composition for the treatment of Alzheimer's disease
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
IL146125A0 (en) Novel quinones as disease therapies
BG103714A (en) Pararacetamol-containing tablet
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
ES2175104T3 (en) STABLE PHARMACEUTICAL COMPOSITIONS, UNDER SOLID FORM.
AU2001233913A1 (en) Bcmp 84, a protein associated to breast cancer
TR200503846T2 (en) Alternative use for modified release insulin sensitiser and use
HU9601684D0 (en) Deuterised active agents in transdermal application
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
GR1003713B (en) Deoxy-sugars as cancer inhibiting agents
ES2147163A1 (en) Pharmaceutical composition with adhesion molecule expression regulating activity
PT1212119E (en) USE OF CIAMEMAZINE IN THE TREATMENT OF BENZODIAZEPINES SUBMITTED WEAR

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees